U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), ...
read more
FDA Approves Lupkynis

FDA Approves Lupkynis

FDA Approves Lupkynis (voclosporin) for Adult Pati...
read more
Third COVID Vaccine Shows Effectiveness; FDA Approves New Treatment

Third COVID Vaccine Shows Effectiveness; FDA Approves New Treatment

MONDAY, Nov. 23, 2020 – Americans were greeted w...
read more
Russia approves ‘Sputnik V’ COVID-19 vaccine with little human testing

Russia approves ‘Sputnik V’ COVID-19 vaccine with little human testing

Russia just approved a coronavirus vaccine for use...
read more
FDA Approves Twirla

FDA Approves Twirla

FDA Approves Twirla (levonorgestrel and ethinyl es...
read more
FDA Approves Pemfexy

FDA Approves Pemfexy

FDA Approves Pemfexy (pemetrexed for injection) as...
read more
FDA Approves Audenz

FDA Approves Audenz

FDA Approves Audenz (Influenza A (H5N1) Monovalent...
read more
FDA approves first drug to help tame cluster headaches

FDA approves first drug to help tame cluster headaches

(HealthDay)— The U.S. Food and Drug Administrati...
read more
FDA approves first gene therapy for spinal muscular atrophy

FDA approves first gene therapy for spinal muscular atrophy

(HealthDay)—The first gene therapy has been appr...
read more